EXPEDITED REVIEW
Coronary Artery Calcification and Changes in Atheroma Burden in Response to Established Medical Therapies
Stephen J. Nicholls, MBBS, PhD, FRACP, FACC*, , ,*,
E. Murat Tuzcu, MD, FACC*,
Kathy Wolski, MPH*,
Ilke Sipahi, MD*,
Paul Schoenhagen, MD*, ,
Timothy Crowe, BS*,
Samir R. Kapadia, MD, FACC*,
Stanley L. Hazen, MD, PhD*, , and
Steven E. Nissen, MD, FACC*
* Cardiovascular Medicine
Cell Biology
Center for Cardiovascular Diagnostics and Prevention
Division of Radiology, Cleveland Clinic, Cleveland, Ohio
Manuscript received April 12, 2006;
revised manuscript received September 21, 2006,
accepted October 16, 2006.
* Reprint requests and correspondence: Dr. Stephen J. Nicholls, Department of Cardiovascular Medicine, Cleveland Clinic, Mail Code JJ65, 9500 Euclid Avenue, Cleveland, Ohio 44195 (Email: nichols1{at}ccf.org).
OBJECTIVES: This study sought to determine the relationship between coronary calcification and plaque progression in response to established medical therapies.
BACKGROUND: Coronary calcification correlates with the extent of atherosclerosis and predicts clinical outcome.
METHODS: Atheroma volume was determined in serial intravascular ultrasound pullbacks in matched arterial segments of 776 patients with angiographic coronary artery disease. A calcium grade at baseline was assigned for each image (total 28,876) (0 = no calcium, 1 = calcium with acoustic shadowing <90° and 2 = calcium with shadowing >90°). Patients with a calcium index (average of calcium scores in a pullback) below versus above the median were compared with regard to plaque burden and progression.
RESULTS: Patients with a high calcium index were older (59 vs. 54 years, p < 0.001), more likely to be male (80% vs. 68%, p < 0.001), and more likely to have a history of hypertension (71% vs. 64%, p = 0.03). These patients had a greater percentage atheroma volume (PAV) (45% vs. 34%, p < 0.001), total atheroma volume (TAV) (210 vs. 151 mm3, p < 0.001), and percentage of images with maximal plaque thickness >0.5 mm (93% vs. 72%, p < 0.001). The continuous rate of change in PAV (1.1 ± 0.4% vs. 0.8 ± 0.4%, p = 0.34) and TAV (1.7 ± 2.1% vs. 0.1 ± 2.2%, p = 0.37) was similar in patients with a lower and higher calcium index, respectively. A lower calcium index was associated with a higher rate of patients showing substantial change in atheroma burden (at least 5% change in PAV, 70% vs. 53%, p < 0.001).
CONCLUSIONS: Calcific plaques are more resistant to undergoing changes in size in response to systemic interventions targeting atherosclerotic risk factors.
|
Abbreviations and Acronyms
| | EEM = external elastic membrane | | IVUS = intravascular ultrasound | | PAV = percentage atheroma volume | | RI = remodeling index | | TAV = total atheroma volume |
|
Related Article
-
Atherosclerosis Regression, Vascular Remodeling, and Plaque Stabilization
- Lloyd W. Klein
J. Am. Coll. Cardiol. 2007 49: 271-273.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
A. C. Montezano, D. Zimmerman, H. Yusuf, D. Burger, A. Z. Chignalia, V. Wadhera, F. N. van Leeuwen, and R. M. Touyz
Vascular Smooth Muscle Cell Differentiation to an Osteogenic Phenotype Involves TRPM7 Modulation by Magnesium
Hypertension,
September 1, 2010;
56(3):
453 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Guasti, F. Marino, T. Congiu, M. Tozzi, L. Schembri, R. C. Maio, L. Castiglioni, L. Maroni, P. Castelli, D. E. Quacci, et al.
Laminar Pattern of Mineral Calcium-Phosphorus Deposits in a Human Carotid Plaque: Nanoscale Ultrastructure and Elemental Analysis
Circulation,
May 4, 2010;
121(17):
1971 - 1973.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Schepis, M. Marwan, T. Pflederer, M. Seltmann, D. Ropers, W. G. Daniel, and S. Achenbach
Quantification of non-calcified coronary atherosclerotic plaques with dual-source computed tomography: comparison with intravascular ultrasound
Heart,
April 1, 2010;
96(8):
610 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hirohata, K. Yamamoto, T. Miyoshi, K. Hatanaka, S. Hirohata, H. Yamawaki, I. Komatsubara, M. Murakami, E. Hirose, S. Sato, et al.
Impact of Olmesartan on Progression of Coronary Atherosclerosis: A Serial Volumetric Intravascular Ultrasound Analysis From the OLIVUS (Impact of OLmesarten on progression of coronary atherosclerosis: evaluation by IntraVascular UltraSound) Trial
J. Am. Coll. Cardiol.,
March 9, 2010;
55(10):
976 - 982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. McCullough and K. M. Chinnaiyan
Annual Progression of Coronary Calcification in Trials of Preventive Therapies: A Systematic Review
Arch Intern Med,
December 14, 2009;
169(22):
2064 - 2070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Lehman, C. L. Schlett, F. Bamberg, H. Lee, P. Donnelly, L. Shturman, M. F. Kriegel, T. J. Brady, and U. Hoffmann
Assessment of Coronary Plaque Progression in Coronary Computed Tomography Angiography Using a Semiquantitative Score
J. Am. Coll. Cardiol. Img.,
November 1, 2009;
2(11):
1262 - 1270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.H. W. Tang
Enhancing the Prognostic Value of Cardiac Imaging With Multimodal Risk Assessment
J. Am. Coll. Cardiol. Img.,
September 1, 2009;
2(9):
1100 - 1102.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Henneman, J. D. Schuijf, G. Pundziute, J. M. van Werkhoven, E. E. van der Wall, J. W. Jukema, and J. J. Bax
Noninvasive Evaluation With Multislice Computed Tomography in Suspected Acute Coronary Syndrome: Plaque Morphology on Multislice Computed Tomography Versus Coronary Calcium Score
J. Am. Coll. Cardiol.,
July 15, 2008;
52(3):
216 - 222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Demer and Y. Tintut
Vascular Calcification: Pathobiology of a Multifaceted Disease
Circulation,
June 3, 2008;
117(22):
2938 - 2948.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Sipahi, E M Tuzcu, K-W Moon, S J Nicholls, P Schoenhagen, J Zhitnik, T D Crowe, S Kapadia, and S E Nissen
Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study
Heart,
May 1, 2008;
94(5):
623 - 627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Kramer
All High-Risk Patients Should Not Be Screened With Computed Tomographic Angiography
Circulation,
March 11, 2008;
117(10):
1333 - 1339.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sanz, P. R. Moreno, and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol.,
March 4, 2008;
51(9):
944 - 955.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the Year in JACC 2007
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
490 - 512.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Klein
Atherosclerosis Regression, Vascular Remodeling, and Plaque Stabilization
J. Am. Coll. Cardiol.,
January 16, 2007;
49(2):
271 - 273.
[Full Text]
[PDF]
|
 |
|
|